Isoprostane nomenclature: Inherent problems may cause setbacks for the development of the isoprostanoid field

Prostaglandins Leukotrienes and Essential Fatty Acids

Volumn 82, Issue 2-3, 2010, Pages 71-81

  Mueller, Martin J ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

Isoprostane nomenclature; Neuroprostanes; Phytoprostanes

Indexed keywords

ARACHIDONIC ACID; ISOPROSTANE; ISOPROSTANOID; LINOLENIC ACID; POLYUNSATURATED FATTY ACID; PROSTAGLANDIN A; PROSTAGLANDIN B; PROSTAGLANDIN D; PROSTAGLANDIN E; PROSTAGLANDIN F; PROSTAGLANDIN G2; PROSTAGLANDIN H; PROSTAGLANDIN RECEPTOR; PROSTANOIC ACID; PROSTANOID; UNCLASSIFIED DRUG;

ARTICLE; BINDING AFFINITY; BIOGENESIS; BIOLOGICAL ACTIVITY; BIOSYNTHESIS; CHEMICAL REACTION; CHEMICAL STRUCTURE; HYDROGEN BOND; LIGAND BINDING; NOMENCLATURE; NONHUMAN; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; RECEPTOR BINDING; STEREOCHEMISTRY;

EID: 77951635880     PISSN: 09523278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.plefa.2009.11.007     Document Type: Review

References (31)

1. Taber D.F., Morrow J.D., Roberts J.J.L. A nomenclature system for isoprostanes. Prostaglandins 1997, 53:63-67.
2. Rokach J., Khanapure S.P., Hwang S.-W., Adiyaman M., Lawson J.A., FitzGerald G.A. Nomenclature of isoprostanes: a proposal. Prostaglandins 1997, 54:853-873.
3. Mueller M.J. Radically novel prostaglandins in animals and plants: the isoprostanes. Chem. Biol. 1998, 5:323-333.
4. Nelson N.A. Prostaglandin nomenclature. J. Med. Chem. 1974, 17:911-918.
5. Roberts L.J., Montine T.J., Markesbery W.R., Tapper A.R., Hardy P., Chemtob S., Dettbarn W.D., Morrow J.D. Formation of isoprostane-like compounds (neuroprostanes) in vivo from docosahexaenoic acid. J. Biol. Chem. 1998, 273:13605-13612.
6. 1 from α-linolenic acid in plants. J. Biol. Chem. 1998, 273:32650-32655.
7. 1) in plants. Plant Physiol. 2000, 124:1293-1303.
8. 1 pathway. Phytochemistry 2003, 62:351-358.
9. Yin H., Morrow J.D., Porter N.A. Identification of a novel class of endoperoxides from arachidonate autoxidation. J. Biol. Chem. 2004, 279:3766-3776.
10. 2-isoprostane regioisomers formed in vivo in the rat. Free Radic. Biol. Med. 1997, 23:943-954.
11. Yin H., Musiek E.S., Gao L., Porter N.A., Morrow J.D. Regiochemistry of neuroprostanes generated from the peroxidation of docosahexaenoic acid in vitro and in vivo. J. Biol. Chem. 2005, 280:26600-26611.
12. 1) from α-linolenic acid in plants. Free Radic. Biol. Med. 2000, 28:720-726.
13. Hamberg M., Svensson J., Wakabayashi T., Samuelsson B. Isolation and structure of two prostaglandin endoperoxides that cause platelet aggregation. Proc. Natl. Acad. Sci. USA 1974, 71:345-349.
14. 2 in the presence of serum albumin. Biochim. Biophys. Acta 1976, 431:183-189.
15. 2. Identification of products formed in vitro. J. Biol. Chem. 1983, 258:11713-11718.
16. 2. Prostaglandins Other Lipid Mediat. 2000, 62:15-21.
17. Negishi M., Sugimoto Y., Ichikawa A. Molecular mechanisms of diverse actions of prostanoid receptors. Biochim. Biophys. Acta 1995, 1259:109-119.
18. Ni F., So S.P., Cervantes V., Ruan K.H. A profile of the residues in the second extracellular loop that are critical for ligand recognition of human prostacyclin receptor. FEBS J. 2008, 275:128-137.
19. Li Y., Zhu F., Vaidehi N., Goddard W.A., Sheinerman F., Reiling S., Morize I., Mu L., Harris K., Ardati A., Laoui A. Prediction of the 3D structure and dynamics of human DP G-protein coupled receptor bound to an agonist and an antagonist. J. Am. Chem. Soc. 2007, 129:10720-10731.
20. Ungrin M.D., Carriere M.C., Denis D., Lamontagne S., Sawyer N., Stocco R., Tremblay N., Metters K.M., Abramovitz M. Key structural features of prostaglandin E(2) and prostanoid analogs involved in binding and activation of the human EP(1) prostanoid receptor. Mol. Pharmacol. 2001, 59:1446-1456.
21. Jahn U., Galano J.M., Durand T. Beyond prostaglandins-chemistry and biology of cyclic oxygenated metabolites formed by free-radical pathways from polyunsaturated fatty acids. Angew. Chem. Int. Ed. Engl. 2008, 47:5894-5955.
22. Hou X., Roberts L.J., Gobeil F., Taber D., Kanai K., Abran D., Brault S., Checchin D., Sennlaub F., Lachapelle P., Varma D., Chemtob S. Isomer-specific contractile effects of a series of synthetic f2-isoprostanes on retinal and cerebral microvasculature. Free Radic. Biol. Med. 2004, 36:163-172.
23. Janssen L.J. Isoprostanes: generation, pharmacology, and roles in free-radical-mediated effects in the lung. Pulm. Pharmacol. Ther. 2000, 13:149-155.
24. Janssen L.J., Tazzeo T. Involvement of TP and EP3 receptors in vasoconstrictor responses to isoprostanes in pulmonary vasculature. J. Pharmacol. Exp. Ther. 2002, 301:1060-1066.
25. Straus D.S., Glass C.K. Cyclopentenone prostaglandins: new insights on biological activities and cellular targets. Med. Res. Rev. 2001, 21:185-210.
26. M. J. Mueller, S. Berger, Reactive electrophilic oxylipins: pattern recognition and signalling. Phytochemistry (2009).
27. 2: an electrophilic trigger of cellular responses. Chem. Res. Toxicol. 2008, 21:138-144.
28. Itoh T., Fairall L., Amin K., Inaba Y., Szanto A., Balint B.L., Nagy L., Yamamoto K., Schwabe J.W. Structural basis for the activation of PPAR gamma by oxidized fatty acids. Nat. Struct. Mol. Biol. 2008, 15:924-931.
29. Dueckershoff K., Mueller S., Mueller M.J., Reinders J. Impact of cyclopentenone-oxylipins on the proteome of Arabidopsis thaliana. Biochim. Biophys. Acta 2008, 1784:1975-1985.
30. Mueller S., Hilbert B., Dueckershoff K., Roitsch T., Krischke M., Mueller M.J., Berger S. General detoxification and stress responses are mediated by oxidized lipids through TGA transcription factors in arabidopsis. Plant Cell 2008, 20:768-785.
31. 1-phytoprostanes trigger plant defense and detoxification responses. Plant Physiol. 2005, 137:328-340.